BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11552717)

  • 1. Epstein-Barr virus-associated gastric lymphomas are distinct from mucosa-associated lymphoid tissue-type lymphomas: genetic abnormalities of p53 gene.
    Chan WY; Chan EK; Chow JH
    Diagn Mol Pathol; 2001 Sep; 10(3):153-60. PubMed ID: 11552717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different roles of p53 between Epstein-Barr virus-positive and -negative gastric carcinomas of matched histology.
    Moritani S; Sugihara H; Kushima R; Hattori T
    Virchows Arch; 2002 Apr; 440(4):367-75. PubMed ID: 11956816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent genomic aberrations in gastric carcinomas associated with Helicobacter pylori and Epstein-Barr virus.
    Chan WY; Liu Y; Li CY; Ng EK; Chow JH; Li KK; Chung SC
    Diagn Mol Pathol; 2002 Sep; 11(3):127-34. PubMed ID: 12218450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic features and expression of Bcl-2 and p53 proteins in primary gastric lymphomas.
    Dogusoy G; Karayel FA; Göcener S; Göksel S
    Pathol Oncol Res; 1999; 5(1):36-40. PubMed ID: 10079376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
    Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
    Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus infection and its gene expression in gastric lymphoma of mucosa-associated lymphoid tissue.
    Xu WS; Chan AC; Lee JM; Liang RH; Ho FC; Srivastava G
    J Med Virol; 1998 Dec; 56(4):342-50. PubMed ID: 9829640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma.
    Du M; Peng H; Singh N; Isaacson PG; Pan L
    Blood; 1995 Dec; 86(12):4587-93. PubMed ID: 8541549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of BCL-6 rearrangements and p53 mutations in Malt-lymphomas.
    Gaidano G; Volpe G; Pastore C; Chiarle R; Capello D; Gloghini A; Perissinotto E; Savinelli F; Bosco M; Mazza U; Pileri S; Palestro G; Carbone A; Saglio G
    Am J Hematol; 1997 Dec; 56(4):206-13. PubMed ID: 9395180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
    Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
    Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan.
    Takahara M; Kishibe K; Bandoh N; Nonaka S; Harabuchi Y
    Hum Pathol; 2004 Jan; 35(1):86-95. PubMed ID: 14745729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway.
    van Rees BP; Caspers E; zur Hausen A; van den Brule A; Drillenburg P; Weterman MA; Offerhaus GJ
    Am J Pathol; 2002 Oct; 161(4):1207-13. PubMed ID: 12368194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics of Epstein-Barr virus-incorporated gastric cancers in Korea.
    Chang MS; Lee HS; Kim CW; Kim YI; Kim WH
    Pathol Res Pract; 2001; 197(6):395-400. PubMed ID: 11432666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic and molecular analyses of acquired immune deficiency syndrome-related and Epstein-Barr virus-associated lymphomas: a comparative study.
    Carbone A; Dolcetti R; Gloghini A; Maestro R; Vaccher E; di Luca D; Tirelli U; Boiocchi M
    Hum Pathol; 1996 Feb; 27(2):133-46. PubMed ID: 8617454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Participation of p53 and bcl-2 Proteins in Gastric Carcinomas Associated with Helicobacterpylori and/or Epstein-Barr Virus (EBV).
    Szkaradkiewicz A; Karpiński TM; Majewski J; Malinowska K; Goślińska-Kuźniarek O; Linke K
    Pol J Microbiol; 2015; 64(3):211-6. PubMed ID: 26638529
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Giammanco A; Anzalone R; Serra N; Graceffa G; Vieni S; Scibetta N; Rea T; Capra G; Fasciana T
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of the 5' noncoding region of the bcl-6 gene in primary gastric lymphomas.
    Go JH; Yang WI; Ree HJ
    Mod Pathol; 2001 May; 14(5):410-4. PubMed ID: 11353050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression.
    Lima VP; de Lima MA; André AR; Ferreira MV; Barros MA; Rabenhorst SH
    World J Gastroenterol; 2008 Feb; 14(6):884-91. PubMed ID: 18240345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-associated high-grade B-cell lymphoma of mucosal-associated lymphoid tissue in a 9-year-old Boy.
    Tao J; Kahn L
    Arch Pathol Lab Med; 2000 Oct; 124(10):1520-4. PubMed ID: 11035588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 11 copy number gains and Epstein-Barr virus-associated malignancies.
    Chan WY; Chan AB; Liu AY; Chow JH; Ng EK; Chung SS
    Diagn Mol Pathol; 2001 Dec; 10(4):223-7. PubMed ID: 11763312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infrequent overexpression of p53 protein in Epstein-Barr virus-associated gastric carcinomas.
    Ojima H; Fukuda T; Nakajima T; Nagamachi Y
    Jpn J Cancer Res; 1997 Mar; 88(3):262-6. PubMed ID: 9140110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.